We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
-13.72%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$9.35B
AUM Growth
-$2.4B
Cap. Flow
-$757M
Cap. Flow %
-8.1%
Top 10 Hldgs %
23.15%
Holding
300
New
33
Increased
109
Reduced
94
Closed
43

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$66.5M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$62.4M
3
TMO icon
Thermo Fisher Scientific
TMO
+$53.8M
4
ANET icon
Arista Networks
ANET
+$47M
5
BSX icon
Boston Scientific
BSX
+$45.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$112M
2
AMGN icon
Amgen
AMGN
+$102M
3
AAPL icon
Apple
AAPL
+$102M
4
ATVI
Activision Blizzard
ATVI
+$72.8M
5
FLEX icon
Flex
FLEX
+$70.4M

Sector Composition

Rank Sector Weight
1 Technology 25.47%
2 Financials 23.51%
3 Healthcare 21.25%
4 Communication Services 7.66%
5 Consumer Discretionary 6.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WOLF icon
151
Wolfspeed
WOLF
$1.24B
$13.2M 0.14%
308,607
+32,860
+12% +$1.33M
BMRN icon
152
BioMarin Pharmaceuticals
BMRN
$11.6B
$13.1M 0.14%
154,370
– –
PNC icon
153
PNC Financial Services
PNC
$99.6B
$12.9M 0.14%
110,545
-729
-0.7% -$93K
GRFS
154
Grifois
GRFS
$5.27B
$12.9M 0.14%
703,370
– –
IMMU
155
DELISTED
Immunomedics Inc
IMMU
$12.9M 0.14%
+904,416
New +$18M
RMD icon
156
ResMed
RMD
$29.5B
$12.5M 0.13%
+110,000
New +$11.8M
DGX icon
157
Quest Diagnostics
DGX
$25.6B
$12.4M 0.13%
149,254
– –
ZGNX
158
DELISTED
Zogenix, Inc.
ZGNX
$12.2M 0.13%
334,569
-116,733
-26% -$4.78M
AZPN
159
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$11.8M 0.13%
143,306
+17,357
+14% +$1.43M
SIEN
160
DELISTED
Sientra, Inc.
SIEN
$11.5M 0.12%
90,390
-9,610
-10% -$1.79M
BDX icon
161
Becton Dickinson
BDX
$43.8B
$11.3M 0.12%
51,277
– –
ARCC icon
162
Ares Capital
ARCC
$13.6B
$11.2M 0.12%
721,732
-10,000
-1% -$165K
FAF icon
163
First American
FAF
$7.79B
$11.2M 0.12%
+250,000
New +$11.6M
JAZZ icon
164
Jazz Pharmaceuticals
JAZZ
$16B
$11.1M 0.12%
89,500
-70,000
-44% -$10.4M
UBS icon
165
UBS Group
UBS
$172B
$10.9M 0.12%
849,839
-8,891
-1% -$121K
MYOK
166
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$10.2M 0.11%
208,193
+116,907
+128% +$6.44M
ALGN icon
167
Align Technology
ALGN
$12B
$10.2M 0.11%
48,554
-66,077
-58% -$16.7M
SLRC icon
168
SLR Investment Corp
SLRC
$705M
$9.66M 0.1%
503,278
– –
PFLT icon
169
PennantPark Floating Rate Capital
PFLT
$692M
$9.53M 0.1%
824,000
+37,315
+5% +$472K
INGN icon
170
Inogen
INGN
$171M
$9.48M 0.1%
+76,379
New +$12.6M
KEYS icon
171
Keysight
KEYS
$53.6B
$9.16M 0.1%
147,591
-252,653
-63% -$15.2M
APTV icon
172
Aptiv
APTV
$12.2B
$9.08M 0.1%
+147,507
New +$10.7M
NSTG
173
DELISTED
NanoString Technologies, Inc.
NSTG
$8.9M 0.1%
600,000
+100,000
+20% +$1.59M
FRC
174
DELISTED
First Republic Bank
FRC
$8.67M 0.09%
99,776
-22,877
-19% -$2.09M
MDGL icon
175
Madrigal Pharmaceuticals
MDGL
$12.7B
$8.45M 0.09%
+75,000
New +$11.6M
5 6
7
8 9

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q4 2018 Portfolio in Review

As of Q4 2018, Polar Capital held 300 positions worth $9.35B, down 20% from $11.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Polar Capital withdrew a net $757M in Q4 2018, closing 43 positions and reducing 94 holdings. Its most notable exit was Activision Blizzard, an estimated $72.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Polar Capital opened a new position in Boston Scientific worth $44.2M.

  • Polar Capital's largest Q4 2018 buy was Boston Scientific: 1,250,000 shares worth $44.2M.
  • Polar Capital added most to Danaher in Q4 2018, an estimated $66.5M increase.
  • Polar Capital's biggest Q4 2018 reduction was Merck, cutting an estimated $112M.
  • Polar Capital fully exited Activision Blizzard in Q4 2018, selling an estimated $72.8M.
  • Polar Capital's ten largest holdings make up 23% of its $9.35B portfolio in Q4 2018.
  • Polar Capital opened 33 new positions and closed 43 in Q4 2018.
  • Polar Capital's portfolio value fell 20% quarter-over-quarter to $9.35B.

Based on Polar Capital's 13F filing for Q4 2018, filed 14 Feb 2019.